Pharmacology, Toxicology and Pharmaceutical Science
Mycobacterium Tuberculosis
100%
Tuberculostatic Agent
29%
Mouse
29%
Mycolic Acid
27%
Carboxamide
27%
Indole
23%
Polyketide Synthase
20%
Membrane Protein
19%
Infection
19%
Antitubercular Activity
15%
Mouse Model
15%
IC50
14%
Antimycobacterial Agent
13%
Structure Activity Relationship
12%
Pharmacokinetics
11%
Drug Resistant Tuberculosis
11%
Bioavailability
11%
Cytotoxicity
10%
Thiol Ester Hydrolase
10%
Lactam
10%
Tofacitinib
10%
Lethality
10%
Rifampicin
10%
Isoniazid
8%
Drug Development
8%
Necrosis
7%
Granuloma
6%
Lead Compound
6%
Cross-Resistance
6%
Oxidoreductase
5%
Minimum Inhibitory Concentration
5%
Tuberculosis
5%
Bacterial Clearance
5%
Benzofuran
5%
Receptor
5%
Mycobacterium abscessus
5%
Mycobacteria
5%
Clorotepine
5%
Pyrazinamide
5%
Salicylic Acid
5%
Diphtheria Toxin
5%
Efficacy Study
5%
Brain Tumor
5%
Methylamine
5%
Adamantane
5%
Benzimidazole
5%
Triclosan
5%
Acyl Carrier Protein
5%
Ciprofloxacin
5%
Fusion Protein
5%
Keyphrases
Mycobacterium Tuberculosis (M. tb)
43%
Tuberculosis
24%
Tuberculosis Treatment
19%
Antitubercular Agents
16%
Mouse Model
13%
N-arylindoles
12%
Host-directed Therapy
12%
Mycobacterial Membrane Protein Large
12%
IC50
11%
Bovine Mastitis
10%
Coumestans
10%
Tofacitinib
10%
Nutrient Utilization
10%
MMP-13 Inhibitors
10%
Antitubercular Activity
8%
Mycolic Acid
8%
H37Rv
7%
Multidrug-resistant Tuberculosis (MDR-TB)
7%
Indoleamide
6%
XDR-tuberculosis
6%
Indole-2-carboxamide
6%
Pks13
6%
Extensively Drug-resistant
5%
Vero Cells
5%
Tuberculosis Drugs
5%
HERG
5%
Gyrase B
5%
Isoniazid Resistance
5%
JHU083
5%
Methylamine
5%
Lymph
5%
Antimycobacterial Evaluation
5%
Adamantanol
5%
Brain Cancer Cells
5%
Milk
5%
Metabolic Inhibition
5%
Endotoxin
5%
MarR
5%
Structure Optimization
5%
Lactams
5%
Partitioning Proteins
5%
Chromosome Partitioning
5%
Tuberculosis Drug Discovery
5%
Immunomodulatory Activity
5%
Glutamine Metabolism
5%
Pyridine-2
5%
Immune Subversion
5%
Pyrido
5%
Pyridinecarboxamides
5%
Biological Evaluation
5%
Immunology and Microbiology
Mycobacterium Tuberculosis
67%
Mouse
21%
Cell Wall
12%
Lymph Node
11%
Macrophage
10%
Mastitis
10%
Infectious Agent
9%
Escherichia coli
9%
Granuloma
8%
Colony-Forming Unit
7%
Wild Type
7%
Cow
7%
Antimicrobial Peptides
6%
Bacilli
6%
Membrane Potential
6%
Immune Response
6%
Colony Forming Unit S
5%
Immunoglobulin M
5%
Mouse Model
5%
RNA Sequencing
5%
Mycobacterium abscessus
5%
Interleukin 8
5%
Metabolic Inhibition
5%
Mycobacterium bovis
5%
Cytokine
5%
Tumor Necrosis Factor
5%
Repressor Gene
5%
Leukocyte Count
5%
Normal Human
5%
Antisense
5%
Lymphocyte Subpopulation
5%
Leukocyte Differential Count
5%
MDA5
5%
Antimicrobial Resistance
5%
Lymphocyte
5%
Cross-Resistance
5%
Carbon Utilization
5%
Intravenous Immunoglobulin
5%
Extensively Drug-Resistant Tuberculosis
5%
Antibacterial Activity
5%
Rabbit Model
5%
